Bauer; S. Christopher

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bauer; S. Christopher.The latest application filed is for "interleukin-3 (il-3) multiple mutation polypeptides".

Company Profile

0.13.9

Bauer; S. Christopher - New Haven MO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
IL-3 variant hematopoiesis fusion protein Grant 7,091,319 - Bauer , et al. August 15, 2	2006-08-15
Interleukin-3 (IL-3) multiple mutation polypeptides App 20050244372 - Bauer, S. Christopher ; et al.	2005-11-03
Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins App 20050059149 - Bauer, S. Christopher ; et al.	2005-03-17
Multi-functional hematopoietic fusion proteins between sequence rearranged G-CSF receptor agonists and other hematopoietic factors App 20040171115 - Feng, Yiqing ; et al.	2004-09-02
Fused G-CSF and IL-3 proteins and uses thereof Grant 6,730,303 - Feng , et al. May 4, 2	2004-05-04
Interleukin-3 (IL-3) mutant polypeptides App 20040018618 - Bauer, S. Christopher ; et al.	2004-01-29
Interleukin-3 (IL-3) multiple mutation polypeptides App 20030220472 - Bauer, S. Christopher ; et al.	2003-11-27
Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production App 20030194783 - McKearn, John P. ; et al.	2003-10-16
Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins App 20030185790 - Bauer, S. Christopher ; et al.	2003-10-02
Methods of ex-vivo expansion of hematopoeitic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors App 20030165461 - Bauer, S. Christopher ; et al.	2003-09-04
Method of ex-vivo expansion of hematopoeitic cells using interleukin-3 (IL-3) multiple mutation polypeptides App 20030103936 - Bauer, S. Christopher ; et al.	2003-06-05
Methods of using multivariant IL-3 hematopoiesis fusion protein Grant 6,361,977 - Bauer , et al. March 26, 2	2002-03-26
Human interleukin-3 (IL-3) variant fusion proteins Grant 6,132,991 - Bauer , et al. October 17, 2	2000-10-17
Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production Grant 6,093,395 - Bauer , et al. July 25, 2	2000-07-25
Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors Grant 6,066,318 - Feng , et al. May 23, 2	2000-05-23
Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors Grant 6,030,812 - Bauer , et al. February 29, 2	2000-02-29
Treatment of hematopoietic disorders with fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors Grant 6,022,535 - Bauer , et al. February 8, 2	2000-02-08
Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines Grant 5,997,860 - Bauer , et al. December 7, 1	1999-12-07
Recombinant human interleukin-3 (IL-3) multiple mutation polypeptides Grant 5,817,486 - Bauer , et al. October 6, 1	1998-10-06
Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors Grant 5,772,992 - Bauer , et al. June 30, 1	1998-06-30
Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them Grant 5,738,849 - Bauer , et al. * April 14, 1	1998-04-14
Interleukin-3 (IL-3) mutant polypeptides and their recombinant production Grant 5,677,149 - Bauer , et al. October 14, 1	1997-10-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.